Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Landau-Kleffner Syndrome (LKS) is a rare neurological disorder. It is characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram (EEG). LKS affects the parts of the brain that control comprehension and speech. The disorder usually occurs in children between the ages of 3 and 6 years old. Typically, children with LKS develop normally for the first few years but then lose their language skills.
How Boston Children's Hospital approaches LKS
The Augmentative Communication Program at Children's treats LKS. Our program is known internationally for its work with children and adults who are non-speaking or whose speech is severely impaired. The program provides comprehensive, state-of-the-art evaluation and treatment for children and adults with congenital or acquired disorders affecting expressive communication, comprehension, and computer access.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”